期刊
ARCHIVES OF WOMENS MENTAL HEALTH
卷 17, 期 3, 页码 239-246出版社
SPRINGER WIEN
DOI: 10.1007/s00737-014-0421-z
关键词
Pregnancy; Depression; Anxiety; Nortriptyline; Pharmacokinetics; Tricyclic antidepressants
类别
资金
- NIMH NIH HHS [T32 MH015144] Funding Source: Medline
Managing depression and anxiety during pregnancy and the postpartum period is challenging. Both pharmacological treatment and the lack thereof can pose threats to a fetus. SSRIs are the drugs of choice for use during pregnancy, but there is considerable evidence for the safety and efficacy of older antidepressants during pregnancy as well. This study highlights a single case of the use of the tricyclic nortriptyline during pregnancy and postpartum. The subject involved had an unexpectedly high ratio of serum level to drug dose during the postpartum period. We monitored the subject for a significantly greater portion of the postpartum period than has been done in previous studies, and explored medical and lifestyle changes that could account for the level-to-dose ratios we observed. Differences in smoking patterns, coupled with the patient's status as a genetic poor metabolizer, were the most likely explanations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据